Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Position Lessened by Horizon Bancorp Inc. IN

Horizon Bancorp Inc. IN trimmed its position in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP) by 27.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 487 shares of the company’s stock after selling 184 shares during the period. Horizon Bancorp Inc. IN’s holdings in Invesco Pharmaceuticals ETF were worth $40,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the company. FMR LLC raised its holdings in Invesco Pharmaceuticals ETF by 29.4% during the third quarter. FMR LLC now owns 1,057 shares of the company’s stock valued at $92,000 after buying an additional 240 shares in the last quarter. Jane Street Group LLC bought a new position in Invesco Pharmaceuticals ETF during the third quarter valued at about $1,163,000. Arete Wealth Advisors LLC bought a new position in Invesco Pharmaceuticals ETF during the third quarter valued at about $402,000. Secure Asset Management LLC bought a new position in Invesco Pharmaceuticals ETF during the third quarter valued at about $229,000. Finally, Joseph Group Capital Management raised its holdings in Invesco Pharmaceuticals ETF by 10.8% during the second quarter. Joseph Group Capital Management now owns 13,001 shares of the company’s stock valued at $1,069,000 after buying an additional 1,272 shares in the last quarter.

Invesco Pharmaceuticals ETF Price Performance

NYSEARCA PJP opened at $82.52 on Tuesday. The stock’s 50-day moving average is $85.03 and its two-hundred day moving average is $85.57. The firm has a market cap of $279.74 million, a P/E ratio of 21.48 and a beta of 0.61. Invesco Pharmaceuticals ETF has a fifty-two week low of $75.33 and a fifty-two week high of $89.87.

Invesco Pharmaceuticals ETF Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.